Philly Pharma Gets Special Zone Powers for Cholesterol Pills
Published Date: 11/26/2025
Notice
Summary
PPL Healthcare, also known as Piramal Pharma Solutions, got the green light to make cholesterol medicine at their Philadelphia facility inside Foreign-Trade Zone 35. This approval lasts three years and means they can produce with some special trade benefits, but if they switch ingredient suppliers or countries, they need to ask for permission again. This move helps Piramal keep costs down and speeds up production while following the rules.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in